Clinical Trial

Efficacy and Safety of GENOSS® SES in Patients With Acute Coronary Syndrome (GENOSS ACS)

Study acronym: GENOSS ACS
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to evaluate the efficacy and safety of the GENOSS SES in patients with acute coronary syndrome (ACS) in real-world pratice.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-10-04; most recent amendment 2026-02-09.
Status change: Recruiting → Active, Not Recruiting 2025-02-16
Trial Details
NCT Number NCT06075368
Lead Sponsor Genoss Co., Ltd.
Conditions Acute Coronary Syndrome, Percutaneous Coronary Intervention
Enrollment 757 participants
Start Date 2020-03-16
Primary Completion 2025-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-11